Pairing Knowledge with Imagination
Imagination is more important than knowledge. Knowledge is limited. Imagination encircles the world.
—Albert Einstein
Imagination is more important than knowledge. Knowledge is limited. Imagination encircles the world.
—Albert Einstein
Albert Einstein’s statement captures the innovative spirit that underlies the drive of the 2017 recipients of ISPE’s Facility of the Year Awards (FOYA) Program, now in its fourteenth year. This annual program represents the heartbeat of our association, and the breath of its members.
This year’s winners, highlighted in the attached 2017 FOYA Supplement, have demonstrated their skill at pairing knowledge with imagination to achieve excellence. They will be honored at the upcoming FOYA Banquet, which will be held during the ISPE/FDA/PQRI Quality Manufacturing Conference, 5–7 June 2017 in Bethesda, Maryland, US.
You can’t really talk about manufacturing without invoking quality—that elusive attribute, equal parts quantitative and qualitative, whose whole is infinitely greater than the sum of its parts. It is both a goal and a fundamental characteristic of the medicines and devices we manufacture.
Quality manufacturing will keep drug shortages at bay and produce safe, effective medicines that are available and accessible to those who need them, wherever they are located. To achieve these lofty goals, industry must embrace a quality culture mindset, and adopt the tools needed to instill that mindset in employees and suppliers.
In this issue, ISPE’s Chair Mike Arnold looks at Industry 4.0 and what it augurs for manufacturing. He likens the next wave of changes to the mobile revolution of the 1990s, and draws parallels with our collective effort to make drugs more accessible and affordable to patients.
Our special report looks at continuous manufacturing from the perspective of the organizers and key presenters of ISPE’s first Continuous Manufacturing conference in April 2016.
And our cover story pays tribute to an engineer’s engineer, who believed in the power of his vision not just for himself, but for the pharmaceutical industry as well.
We can’t manufacture imagination. Excellence, on the other hand, we can: by training our students and Young Professionals to value it, our middle managers to foster it, and our executives to recognize and reward it. By embracing change and planning for it.
It won’t be long before Industry 4.0 has reached beyond manufacturing to change the way patients access and use drugs, or for the pharmaceutical manufacturing industry to reimagine what it means to manufacture drugs and medical devices. And for the drugs themselves to be reinvented by the biopharmaceutical sector.
Industry professionals around the world are conceiving a new architecture of drug manufacturing. We at ISPE are here to support, reward, and recognize it.
Personalized medicine provides a treatment alternative that utilizes patients’ genetic material to produce therapeutics. According to Market Research Future, the US currently accounts for the largest share of the personalized medicine market, and it is expected to reach US $27.5 million by 2030.
Over time and with effort and determination, women in key leadership positions have proven that these positions are genderless for individuals with the correct set of abilities and knowledge.
ISPE has started 2024 with great momentum, having two technical conferences in the first quarter, the 2024 ISPE Facilities of the Future Conference in San Francisco, California and the 2024 ISPE...